EP2953633
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.2.2014EP published:
4.10.2017EP application number:
14748994.2
EPO information:
European Patent Register
Max expiry date:
4.2.2034
Title:
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Timeline
Today
5.2.2014EP application
4.10.2017EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, 94305-2038, Stanford, CA, US
Name:
The United States of America, as represented by The Secretary, Department of Health and Human ServicesAddress:
6011 Executive Boulevard Suite 325, MSC 7660, 20892-7660, Bethesda, Maryland, US
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, 94607-5200, Oakland, CA, US
Inventor
Name:
WEISKOPF, KippAddress:
Menlo Park, California, US
Name:
HASENKRUG, Kim J.Address:
Victor Montana, US
Name:
STODDART, Cheryl.A.Address:
Pacifica,California, US
Name:
MCCUNE, Joseph M.Address:
San Francisco,California, US
Name:
WEISSMAN, Irving L.Address:
Stanford, California, US
Priority
Number:
201361761133 PDate:
5.2.2013Country:
US
Classification
Categories:
A61K 35/00, A61P 31/12